Space Pharmaceuticals AG will participate in Peptide Therapeutics Forum 2026, taking place on June 4, 2026, at Biozentrum Basel, Switzerland. During the Contributed Talks session at 14:00, Sacha Javor, CTO of Space Peptides, will present:

AI-driven peptide drug discovery enables sub-6-month identification of clinically validated binders.

The presentation will highlight how Space Pharm integrates artificial intelligence, molecular modelling, and rapid experimental validation to accelerate peptide drug discovery and shorten the design-to-validation timeline to under six months. The talk will also share progress from a CCR8-targeting peptide inhibitor program, demonstrating the platform’s potential to identify high-affinity peptide candidates with translational relevance.

We welcome researchers, partners, and innovators in peptide therapeutics, AI-enabled drug discovery, and molecular modelling to connect with us in Basel.